Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 80
Selected: 0
NCT IDTitle
NCT00220064A Phase II Trial Evaluating Irinotecan Plus 5FU/LV in Patients With Relapsed/Refractory Upper GI Tumours
NCT00193037Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer
NCT01640782Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach
NCT03004001Effect of PCSK9-Antibody (Alirocumab) on Dyslipidemia Secondary to Nephrotic Syndrome
NCT00087035Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer
NCT00196651HIV Immune and Virological Responses Following the Administration of IL-2 Either Alone or Combined to ALVAC-HIV 1433 and HIV Lipopeptides in Patients Treated Early With HAART During Primary Infection
NCT00149175Clinical and Genetic Study of Neurodegenerative Disorders With Cognitive Impairment
NCT00198237Genomic & Proteomic Analysis of Docetaxel & Capecitabine as Primary Chemo for Stage II-III Breast Cancer
NCT00256789Once Weekly Radiation for Lung Cancer With Chemotherapy
NCT00216008Pharmacogenomic Study of Docetaxel and Cisplatin, Followed by Docetaxel, Cisplatin and Irradiation.
NCT00183924Estramustine, Docetaxel, and Carboplatin for Patients With Hormone Refractory Prostate Cancer Progressing After Mitoxantrone-Based Chemotherapy.
NCT00318903Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancer
NCT00148070Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast Cancer
NCT01652820Chemotherapy/Radiotherapy Versus Concomitant Chemotherapy Followed by Radiotherapy in Stage IIIB Non-small Cell Lung Cancer
NCT00232479Dose Dense Carboplatin, Taxotere and Herceptin As Primary Systemic Therapy in Breast Cancer
NCT00168896A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage
NCT00122564Study of HIV-1 Rgp-160 Administered by Mucosal Routes in Healthy Volunteers
NCT00186420Adjuvant Taxotere in Patients With High Risk Prostate Cancer Post Prostatectomy and Radiation
NCT00193050Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast Cancer
NCT00090610Second-Line Treatment for Patients With Platinum-Sensitive Ovarian Cancer
NCT00183794Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma
NCT00193232Weekly Docetaxel and Bortezomib in the Treatment of Advanced Hormone-Refractory Prostate Cancer
NCT00043576ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere
NCT00193284Chemotherapy Plus Gefitinib Followed by Chemotherapy, Radiation Therapy, and Gefitinib For Head and Neck Cancer
NCT00426127Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic Cancer
NCT00193128Preoperative Therapy With Oxaliplatin/Docetaxel/Capecitabine and Radiation in Resectable Esophagus Cancer
NCT00240747Open-label, Multiple-dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric Patients
NCT00189449Effects of Long-Term Treatment With Nasally Inhaled Triamcinolone Acetonide in Children With Allergic Rhinitis
NCT00151073Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate
NCT00822471Feasibility and Impact of "ABCs of Diabetes" Self-Management Education Program at an Urban Public Library
NCT00194558Outcomes and Cost Consequences of Using an Internet Co-Management Module to Improve the Quality of Type 1 Diabetes Care
NCT00121758AIDS Vaccine Study Comparing Immunogenicity and Safety of 3 Doses of Lipopeptides Versus Placebo in Non Infected HIV Volunteers
NCT00390429Docetaxel and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors
NCT00270894Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients
NCT00280735Ph II Adjuvant Carboplatin/Docetaxel in Curatively Resected Stage I-IIIA NSCLC
NCT00257348Capecitabine and Docetaxel in Advanced/Recurrent Cervical Cancer
NCT00291590Diabetes Health Enhancement Program to Improve Health of People With Diabetes
NCT00176059Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients
NCT00193427Preoperative Therapy in Patients With Stages IB, II, IIIA, and Selected IIIB Patients With Non-Small Cell Lung Cancer
NCT00193245Oral Topotecan Versus Docetaxel in Second-Line Treatment of Non-Small Cell Lung Cancer
NCT00193180Docetaxel Plus Imatinib Mesylate in Metastatic Breast Cancer
NCT00170378The Use of Low Molecular Weight Heparin in Traumatic Brain Injury
NCT00288444Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer
NCT00193089Docetaxel, Vinorelbine and Trastuzumab in the Treatment of Patients With Metastatic Her-2 Positive Breast Cancer
NCT00193024Epirubicin and Docetaxel in the Treatment of Patients With Metastatic Breast Cancer
NCT00279916Short Term Relief of Eustachian Tube Dysfunction and Serous Otitis Media Using Intranasal Steroid Sprays
NCT00177255A Study of Docetaxel in Combination With Capecitabine in Stomach and Esophagus Cancers
NCT00193011Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast Cancer
NCT00190411Celiprolol in Patients With Ehlers-Danlos Syndrome, Vascular Type
NCT001896575FU/VL Vs LV5FU2 + CPT11 in Stage II-III Resected Rectal Cancer